Page last updated: 2024-08-16

resveratrol and Cholangiocarcinoma

resveratrol has been researched along with Cholangiocarcinoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Fan, Z; He, W; Jiang, R; Na, C; Qi, L; Zhang, A1
Braidotti, P; Branchi, F; Doneda, L; Elli, L; Lombardo, V; Roncoroni, L; Scricciolo, A; Tacchini, L; Tosi, D; Vaira, V1
Ferraresi, A; Isidoro, C; Loilome, W; Namwat, N; Thongchot, S; Vidoni, C; Yongvanit, P1
DeMorrow, S; Frampton, GA; Lazcano, EA; Li, H; Mohamad, A1
Bardella, MT; Dogliotti, E; Dolfini, E; Doneda, L; Elli, L; Erba, E; Grimoldi, MG; Roncoroni, L; Terrani, C1

Other Studies

5 other study(ies) available for resveratrol and Cholangiocarcinoma

ArticleYear
FOXO1, a Potential Therapeutic Target, Regulates Autophagic Flux, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Human Cholangiocarcinoma QBC939 Cells.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 45, Issue:4

    Topics: Acetylation; Apoptosis; Autophagy; Autophagy-Related Protein 7; Bile Duct Neoplasms; Cell Line, Tumor; Cholangiocarcinoma; Forkhead Box Protein O1; Humans; Membrane Potential, Mitochondrial; Microtubule-Associated Proteins; Oxidative Stress; Resveratrol; RNA Interference; RNA, Small Interfering; Sequestosome-1 Protein; Stilbenes

2018
Transglutaminase 2 Mediates the Cytotoxicity of Resveratrol in a Human Cholangiocarcinoma and Gallbladder Cancer Cell Lines.
    Nutrition and cancer, 2018, Volume: 70, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Bile Duct Neoplasms; Cell Line, Tumor; Cholangiocarcinoma; Cystamine; Enzyme Inhibitors; Gallbladder Neoplasms; GTP-Binding Proteins; Humans; Karyotyping; Microscopy, Electron, Transmission; Protein Glutamine gamma Glutamyltransferase 2; Resveratrol; Transglutaminases

2018
Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells.
    Cancer letters, 2018, 08-28, Volume: 430

    Topics: Antigens, CD; Antineoplastic Agents, Phytogenic; Autophagy; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cadherins; Cancer-Associated Fibroblasts; Cell Communication; Cell Movement; Cholangiocarcinoma; Culture Media, Conditioned; Epithelial Cells; Humans; Interleukin-6; Primary Cell Culture; Resveratrol; Tumor Cells, Cultured

2018
Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents.
    Laboratory investigation; a journal of technical methods and pathology, 2010, Volume: 90, Issue:9

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cholangiocarcinoma; Cytochrome P-450 Enzyme System; Deoxycytidine; Fluorouracil; Gemcitabine; Mice; Mice, Nude; Mitomycin; Resveratrol; Stilbenes

2010
Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line.
    Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:10

    Topics: Alkaline Phosphatase; Cell Line, Tumor; Cell Survival; Cholangiocarcinoma; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Enzyme Activation; Flow Cytometry; Fluorescent Antibody Technique; Humans; Karyotyping; L-Lactate Dehydrogenase; Microscopy, Electron, Scanning; Resveratrol; Stilbenes; Transglutaminases

2008